LOGIN  |  REGISTER
Terns Pharmaceuticals
Amneal Pharmaceuticals

Centene To Present At Bank Of America 2024 Global Healthcare Conference

September 11, 2024 | Last Trade: US$76.32 0.93 1.23

TOPLINE SUMMARY

• Centene Corporation will present at the Bank of America 2024 Global Healthcare Conference in London.
• The company is a leading healthcare enterprise committed to helping people live healthier lives.
• Centene will present on Wednesday, Sept. 18, 2024, at 5:50 am EDT /10:50 am BST.

ST. LOUIS, Sept. 11, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it will present at the Bank of America 2024 Global Healthcare Conference in London. Centene will present on Wednesday, Sept. 18, 2024, at 5:50 am EDT /10:50 am BST. A simultaneous live audio webcast will be available at: https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2024/x1aRN0.cfm.

A webcast replay will be available following the presentation on Centene's website, www.centene.com, under the Investors section.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program.

Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/.

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB